The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 161.03 USD. With the latest stock price at 127.88 USD, the upside of Neurocrine Biosciences Inc based on DCF is 25.9%.
Based on the latest price of 127.88 USD and our DCF valuation, Neurocrine Biosciences Inc (NBIX) is a buy. buying NBIX stocks now will result in a potential gain of 25.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.2% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 107.77 - 344.99 | 161.03 |
| Upside | -15.7% - 169.8% | 25.9% |